Wnt antagonism inhibits hepatic stellate cell activation and liver fibrosis
about
β-catenin regulates mesenchymal progenitor cell differentiation during hepatogenesisKey Fibrogenic SignalingPotential role of thymosin Beta 4 in liver fibrosisβ-Catenin Signaling and Roles in Liver Homeostasis, Injury, and TumorigenesisNon-Canonical Wnt Predominates in Activated Rat Hepatic Stellate Cells, Influencing HSC Survival and Paracrine Stimulation of Kupffer CellsMest attenuates CCl4-induced liver fibrosis in rats by inhibiting the Wnt/β-catenin signaling pathwayBeta-catenin/T-cell factor signaling is activated during lung injury and promotes the survival and migration of alveolar epithelial cellsSelective inhibitor of Wnt/β-catenin/CBP signaling ameliorates hepatitis C virus-induced liver fibrosis in mouse model.Enhanced Wnt Signalling in Hepatocytes is Associated with Schistosoma japonicum Infection and Contributes to Liver Fibrosis.Role of the Wnt/β-catenin signaling pathway in inducing apoptosis and renal fibrosis in 5/6-nephrectomized ratsRegulators of Cholangiocyte Proliferation.The roles of microRNA families in hepatic fibrosis.Anchoring hepatic gene expression with development of fibrosis and neoplasia in a toxicant-induced fish model of liver injuryThe role of stem cells in liver repair and fibrosisInhibition of connective tissue growth factor overexpression in diabetic retinopathy by SERPINA3K via blocking the WNT/beta-catenin pathway.The small molecule indirubin-3'-oxime activates Wnt/β-catenin signaling and inhibits adipocyte differentiation and obesity.Activation of WNT/β-catenin signaling in pulmonary fibroblasts by TGF-β₁ is increased in chronic obstructive pulmonary disease.The Necdin-Wnt pathway causes epigenetic peroxisome proliferator-activated receptor gamma repression in hepatic stellate cells.Beta-catenin signaling, liver regeneration and hepatocellular cancer: sorting the good from the bad.Beta-catenin is elevated in human benign prostatic hyperplasia specimens compared to histologically normal prostate tissue.Expression of Septin4 in Schistosoma japonicum-infected mouse livers after praziquantel treatmentComplete response of Ctnnb1-mutated tumours to β-catenin suppression by locked nucleic acid antisense in a mouse hepatocarcinogenesis modelTGF-β-activated kinase 1 (TAK1) signaling regulates TGF-β-induced WNT-5A expression in airway smooth muscle cells via Sp1 and β-catenin.Imbalance of Wnt/Dkk negative feedback promotes persistent activation of pancreatic stellate cells in chronic pancreatitis.Pigment epithelium-derived factor 34-mer peptide prevents liver fibrosis and hepatic stellate cell activation through down-regulation of the PDGF receptor.Potent effects of dioscin against liver fibrosis.Novel insights into the function and dynamics of extracellular matrix in liver fibrosis.Expression2Kinases: mRNA profiling linked to multiple upstream regulatory layersPigment epithelium-derived factor regulates early pancreatic fibrotic responses and suppresses the profibrotic cytokine thrombospondin-1.Abnormal Accumulation of Collagen Type I Due to the Loss of Discoidin Domain Receptor 2 (Ddr2) Promotes Testicular Interstitial Dysfunction.Axin pathway activity regulates in vivo pY654-β-catenin accumulation and pulmonary fibrosis.The Wnt/β-catenin signaling pathway in liver biology and disease.Retinoic Acid Ameliorates Pancreatic Fibrosis and Inhibits the Activation of Pancreatic Stellate Cells in Mice with Experimental Chronic Pancreatitis via Suppressing the Wnt/β-Catenin Signaling Pathway.Hepatic stellate cell-derived delta-like homolog 1 (DLK1) protein in liver regeneration.Morphogens and hepatic stellate cell fate regulation in chronic liver disease.Transcriptional regulation of methionine adenosyltransferase 2A by peroxisome proliferator-activated receptors in rat hepatic stellate cells.Wnt Pathway Stabilizes MeCP2 Protein to Repress PPAR-γ in Activation of Hepatic Stellate CellsThe crucial role of cholangiocytes in cholangiopathiesPigment Epithelium-Derived Factor (PEDF) Inhibits Wnt/β-catenin Signaling in the LiverEffect of Insulin Resistance on Monounsaturated Fatty Acid Levels: A Multi-cohort Non-targeted Metabolomics and Mendelian Randomization Study
P2860
Q24608542-DC0F7F89-9CFC-4D99-B7D7-CDEB72F26357Q26995788-EED3B482-DCA4-476E-B062-2734A26E397DQ27003833-ACE3C8E7-FC34-48E1-BABD-B7D32EC45FD8Q28087660-993A9BCB-44EE-4C76-A8D8-EBEB57B84EC4Q28269801-14581EE6-4F75-4D6D-B4ED-FE784A342C5CQ33633669-008AB1DF-A502-4E32-B376-C626DC71BA16Q33661599-9D927381-A879-46DA-BE46-5038948E4AFDQ33669920-225382FC-8D14-4999-A89B-CC21DF698267Q33671258-235C0EB4-0211-42B0-918A-862422A0E992Q33702273-45A9A615-88E7-4BB1-A235-F8711C9AF788Q33863341-15DE783F-8AE0-49E0-B666-3065144C053AQ33868794-8CED936F-C7DB-4A18-A3D6-8AFBD9C24FF5Q33894802-6A8704E8-0367-45C7-BEB9-A8B0ABA8A099Q33925732-3DE736C0-112F-4DA0-9451-49158622FFE8Q33930328-2EF5488E-52B3-429D-858D-C64F58A5AE00Q34018084-38EFEC39-D36D-4757-9999-4990BD349C80Q34043208-65DD99D0-4F96-4074-A30B-510B1027AD77Q34155250-595BA782-0E74-403F-9A59-951E673E65CAQ34630557-A7D62809-F542-4F19-A950-9CE182ED4F11Q34978719-8A505345-779D-46ED-B292-67DA1E51B533Q34984531-24A74FA7-6441-4994-A95C-D50E4C26003AQ34989670-81875031-D102-4676-9731-5665218751A0Q35146881-6A1E3D47-EF15-4776-B6D5-47F1142ADA7EQ35152912-9581B0DB-905E-4D81-8293-731DB03A18F8Q35156869-627B3A9A-E30D-44EF-BFB5-23D887B13596Q35317884-4A645E5B-F7D4-425E-8C7C-1797971E2D3AQ35622533-D30D11D2-005A-4A9F-96F9-250FB291414CQ35630203-8A8DDE53-2B85-477B-B4C1-F5985FDE6624Q35679338-EF8C93B5-23CC-4DF4-8375-8B80A11FAD82Q35686900-2642A7A0-25EF-4434-BBCE-32B0BF2144A5Q35762900-12AB1109-A4D9-4E2C-AD5C-41CC8291727AQ35819799-B1635C79-81BA-418C-91F0-3F4C2AA0E96CQ35837893-76CF009D-7439-43B8-9BC6-5EF6025E1F6FQ35880000-6B986C44-FAAE-4E02-AE25-2E3CB2B44F34Q35914173-32EFAC4C-ABBC-4EE3-A479-693E79BF23C7Q35928499-E7E27E03-0211-41B4-972D-2E76550FF630Q36026774-1244C78D-B541-4A88-AE39-8F82D1723BB6Q36113261-160AD36C-8B2B-4988-9F9F-1BE6B1F59A70Q36157238-DF91FA34-BFF9-4177-8019-3D2996C1B03EQ36170653-221ED912-1C3F-4CA7-BE9B-6AEEEF09B1E2
P2860
Wnt antagonism inhibits hepatic stellate cell activation and liver fibrosis
description
2008 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հունվարին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2008
@ast
scientific journal article
@en
vedecký článok (publikovaný 2008/01/01)
@sk
vědecký článek publikovaný v roce 2008
@cs
wetenschappelijk artikel (gepubliceerd op 2008/01/01)
@nl
наукова стаття, опублікована в січні 2008
@uk
مقالة علمية (نشرت عام 2008)
@ar
name
Wnt antagonism inhibits hepatic stellate cell activation and liver fibrosis
@ast
Wnt antagonism inhibits hepatic stellate cell activation and liver fibrosis
@en
Wnt antagonism inhibits hepatic stellate cell activation and liver fibrosis
@nl
type
label
Wnt antagonism inhibits hepatic stellate cell activation and liver fibrosis
@ast
Wnt antagonism inhibits hepatic stellate cell activation and liver fibrosis
@en
Wnt antagonism inhibits hepatic stellate cell activation and liver fibrosis
@nl
prefLabel
Wnt antagonism inhibits hepatic stellate cell activation and liver fibrosis
@ast
Wnt antagonism inhibits hepatic stellate cell activation and liver fibrosis
@en
Wnt antagonism inhibits hepatic stellate cell activation and liver fibrosis
@nl
P2093
P2860
P3181
P356
P1476
Wnt antagonism inhibits hepatic stellate cell activation and liver fibrosis
@en
P2093
Hidekazu Tsukamoto
Hongyun She
Jason H. Cheng
Jiaohong Wang
Kinji Asahina
Shigang Xiong
Yuan-Ping Han
P2860
P304
P3181
P356
10.1152/AJPGI.00263.2007
P577
2008-01-01T00:00:00Z